1 Follicular Lymphoma: Epidemiology, Pathogenesis and Initiating Events
Zi Yun Ng, Connull Leslie, Chan Yoon Cheah
2 Pathologic Features, Grading and Variants of Follicular Lymphoma
Ali Sakhdari, Roberto N. Miranda
3 Genomic Drivers in Follicular Lymphoma
Saber Tadros, Michael R. Green
4 The Microenvironment in Follicular Lymphoma
Nahum Puebla-Osorio, Paolo Strati, Sattva S. Neelapu
5 Prognostic Factors in Follicular Lymphoma
Anna Johnston, Judith Trotman
II Current Therapy for Follicular Lymphoma
6 Management of Localized Low-Grade Follicular Lymphoma
Neil B. Desai, Sarah A. Milgrom
7 Current Management and Novel Approaches to the Management of Follicular Lymphoma
Jonathon B. Cohen, Brad S. Kahl
8 Transformed Follicular Lymphoma
Michael J. Leukam, Sonali M. Smith
9 Cellular Therapy for Follicular Lymphoma
Ok-kyong Chaekal, Paolo Strati, Koen van Besien
III Emerging therapy in Follicular Lymphoma
10 Antibody Therapy in Follicular Lymphoma
J. C. Villasboas, Grzegorz S. Nowakowski
11 Molecular Targeting in Follicular Lymphoma
Loretta J. Nastoupil
Nathan H. Fowler, MD
University of Texas
MD Anderson Cancer Center
Department of Lymphoma/Myeloma
Houston, TX
USA
This book provides a comprehensive, state-of-the-art overview of follicular lymphoma. The first section of the text explores the current understanding of the biology and pathogenesis of follicular lymphoma, through reviewing recent changes in the WHO classification of low-grade lymphomas, current diagnostic techniques, and emerging research on the importance of the immune microenvironment. The second section focuses on current treatment for localized disease, advanced stage disease, and transformed follicular lymphomas, and details currently FDA approved regimens and evolving radiation techniques for early stage and advanced disease. The last section of the text presents emerging approaches in targeted, immunologic, and vaccine therapy.
Written by experts in the field, Follicular Lymphoma: Current Management and Novel Approaches is a valuable resource for practicing clinicians, practitioners, and researchers who manage and have an interest in follicular lymphoma.